Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2017 Jul;2(5):449-456.
doi: 10.1016/j.bpsc.2017.03.019. Epub 2017 Apr 6.

Metabotropic Glutamate Receptor 5 and Glutamate Involvement in Major Depressive Disorder: A Multimodal Imaging Study

Chadi G Abdallah  1   2 , Jonas Hannestad  3 , Graeme F Mason  1   4 , Sophie E Holmes  1 , Nicole DellaGioia  1 , Gerard Sanacora  1   2 , Lihong Jiang  4 , David Matuskey  1   4 , Ritvij Satodiya  1   2 , Fabrizio Gasparini  5 , Xin Lin  6   7 , Jonathan Javitch  6   8   7 , Beata Planeta  4 , Nabeel Nabulsi  4 , Richard E Carson  4 , Irina Esterlis  1   2   4
Affiliations

Metabotropic Glutamate Receptor 5 and Glutamate Involvement in Major Depressive Disorder: A Multimodal Imaging Study

Chadi G Abdallah et al. Biol Psychiatry Cogn Neurosci Neuroimaging. 2017 Jul.

Abstract

Background: Preclinical and postmortem studies have implicated the metabotropic glutamate receptor 5 (mGluR5) in the pathophysiology of major depressive disorder (MDD). The goal of the present study was to determine the role of mGluR5 in a large group of individuals with MDD compared to healthy controls (HC) in vivo with [18F]FPEB and positron emission tomography (PET). Furthermore, we sought to determine the role glutamate plays on mGluR5 availability in MDD.

Methods: Sixty-five participants (30 MDD and 35 HC) completed [18F]FPEB PET to estimate the primary outcome measure - mGluR5 volume of distribution (VT), and the secondary outcome measure - mGluR5 distribution volume ratio (DVR). A subgroup of 39 participants (16 MDD and 23 HC) completed proton magnetic resonance spectroscopy (1H MRS) to estimate anterior cingulate (ACC) glutamate, glutamine, and Glx (glutamate + glutamine) levels relative to creatine (Cr).

Results: No significant between-group differences were observed in mGluR5 VT or DVR. Compared to HC, individuals with MDD had higher ACC glutamate, glutamine, and Glx levels. Importantly, the ACC mGluR5 DVR negatively correlated with glutamate/Cr and Glx/Cr levels.

Conclusions: In this novel in vivo examination, we show an inverse relationship between mGluR5 availability and glutamate levels. These data highlight the need to further investigate the role of glutamatergic system in depression.

Keywords: 1H MRS; MDD; PET; [18F]FPEB; glutamate; mGluR5.

PubMed Disclaimer

Figures

Figure 1
Figure 1. Glutamate level in the anterior cingulate cortex (ACC)
(A) The levels of glutamate (Glu), glutamine (Gln), and glutamate+glutamine (Glx) in the ACC of patients with MDD (red) compared to healthy (blue). (B–D) Scatter plots of the correlations between metabotropic glutamate receptor 5 (mGluR5) distribution volume ratio (DVR) in the whole group and ACC levels of glutamate (B), glutamine (C), and Glx (D). Abbreviations: (A) *, p ≤ 0.05, Bars/Error-bars: Mean/SEM; (B–D) shaded areas are the 95% confidence band of the best-fit line.
See this image and copyright information in PMC

References

    1. Mathers C, Fat DM, Boerma J. The global burden of disease: 2004 update. World Health Organization; 2008.
    1. Abdallah CG, Sanacora G, Duman RS, Krystal JH. Ketamine and rapid-acting antidepressants: a window into a new neurobiology for mood disorder therapeutics. Annu Rev Med. 2015;66:509–523. - PMC - PubMed
    1. Wieronska JM, Pilc A. Metabotropic glutamate receptors in the tripartite synapse as a target for new psychotropic drugs. Neurochem Int. 2009;55:85–97. - PubMed
    1. Krystal JH, Mathew SJ, D’Souza DC, Garakani A, Gunduz-Bruce H, Charney DS. Potential psychiatric applications of metabotropic glutamate receptor agonists and antagonists. CNS Drugs. 2010;24:669–693. - PubMed
    1. Niciu MJ, Ionescu DF, Richards EM, Zarate CA., Jr Glutamate and its receptors in the pathophysiology and treatment of major depressive disorder. J Neural Transm (Vienna) 2014;121:907–924. - PMC - PubMed

LinkOut - more resources